This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.
Protocol Amendment History
14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2024-01-05; most recent amendment 2026-02-20.
Status change: Not Yet Recruiting → Recruiting2024-05-20